Budget impact analysis of cenobamate, a novel adjunctive therapy for the treatment of drug resistant focal onset seizures, from the Belgian healthcare payer perspective. - Vonck K; Bodart O; Weckhuysen S; Tanghe A; Callebaut B; Verdonck C; Van den Bergh L; Legros B (Journal of medical economics, 2025)